The impact of the time to start radiotherapy (TRT) on overall survival in newly diagnosed glioblastoma.

被引：0
|
作者：
Santos, Vanessa Montes [1 ]
Mesquita, Marcella Coelho [1 ]
Estevez-Diz, Maria Del Pilar [1 ]
Marta, Gustavo N. [1 ]
Feher, Olavo [1 ]
机构：
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2040
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
    Press, Robert H.
    Shafer, Sarah L.
    Jiang, Renjian
    Buchwald, Zachary S.
    Abugideiri, Mustafa
    Tian, Sibo
    Morgan, Tiffany
    Behera, Madhusmita
    Sengupta, Soma
    Voloschin, Alfredo Daniel
    Olson, Jeffrey J.
    Curran, Walter John, Jr.
    Eaton, Bree Ruppert
    Shu, Hui-Kuo George
    Zhong, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [12] The Impact of Intraoperative MRI and Other Factors on Survival for Patients With Newly Diagnosed Glioblastoma. A Multicenter Assessment of Over 800 Patients
    Shah, Amar S.
    Sylvester, Peter
    Vellimana, Ananth K.
    Dunn, Gavin P.
    Evans, John
    Jensen, Randy L.
    Honeycutt, John H.
    Sutherland, Garnette R.
    Cahill, Daniel P.
    Shah, Mitesh V.
    Abram, Steven R.
    Oswood, Mark C.
    Kim, Albert H.
    Leuthardt, Eric C.
    Dowling, Joshua L.
    Rich, Keith M.
    Dacey, Ralph G.
    Zipfel, Gregory J.
    Tao, Yu
    Chicoine, Michael R.
    NEUROSURGERY, 2018, 65 : 120 - 121
  • [13] Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma
    Hemi Malkki
    Nature Reviews Neurology, 2014, 10 (4) : 179 - 179
  • [14] The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study
    Lau, Arthur C. K.
    Chan, Brandon L. H.
    Yeung, Carly S. K.
    Li, Lai-Fung
    Chan, Danny T. M.
    Lee, Michael W. Y.
    Chan, Tony K. T.
    Ho, Jason M. K.
    Cheung, Ka-Man
    Tse, Teresa P. K.
    Lau, Sarah S. N.
    Chow, Joyce S. W.
    Ko, Natalie M. W.
    Loong, Herbert H. F.
    El-Helali, Aya
    Poon, Wai-Sang
    Woo, Peter Y. M.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [15] AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
    Chinot, O. L.
    Wick, W.
    Saran, F.
    Mason, W. P.
    Henriksson, R.
    Nishikawa, R.
    Zeaiter, A. H.
    Moore, N.
    Das, A.
    Cloughesy, T. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [16] Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival
    Matthias Schneider
    Anna-Laura Potthoff
    Elisa Scharnböck
    Muriel Heimann
    Niklas Schäfer
    Johannes Weller
    Christina Schaub
    Andreas H. Jacobs
    Erdem Güresir
    Ulrich Herrlinger
    Hartmut Vatter
    Patrick Schuss
    Journal of Neuro-Oncology, 2020, 149 : 421 - 427
  • [17] Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme
    Lipani, John D.
    Jackson, Paul S.
    Soltys, Scott G.
    Sato, Kengo
    Adler, John R.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2008, 7 (03) : 249 - 255
  • [18] A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme
    Rades, Dirk
    Witteler, Jaspar
    Schild, Steven E.
    Trillenberg, Peter
    Bonsanto, Matteo M.
    Leppert, Jan
    ANTICANCER RESEARCH, 2021, 41 (01) : 379 - 384
  • [19] Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity
    Gruber, M. L.
    Raza, S.
    Gruber, D.
    Narayana, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [20] Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation status
    Alafandi, A.
    van Garderen, K. A.
    Klein, S.
    van der Voort, S. R.
    Rizopoulos, D.
    Nabors, L.
    Stupp, R.
    Weller, M.
    Gorlia, T.
    Tonn, J. -c.
    Smits, M.
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 122 - 130
12345